Sandra Motas

767 total citations
6 papers, 359 citations indexed

About

Sandra Motas is a scholar working on Physiology, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Sandra Motas has authored 6 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 3 papers in Molecular Biology and 3 papers in Cognitive Neuroscience. Recurrent topics in Sandra Motas's work include Lysosomal Storage Disorders Research (5 papers), Autism Spectrum Disorder Research (3 papers) and Retinal Development and Disorders (2 papers). Sandra Motas is often cited by papers focused on Lysosomal Storage Disorders Research (5 papers), Autism Spectrum Disorder Research (3 papers) and Retinal Development and Disorders (2 papers). Sandra Motas collaborates with scholars based in Spain, France and United States. Sandra Motas's co-authors include Virginia Haurigot, Miquel García, Fátima Bosch, Albert Ribera, Jesús Ruberte, Sara Marcó, Pilar Villacampa, Maria Molas, Luca Maggioni and Sergio Muñoz and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Human Molecular Genetics.

In The Last Decade

Sandra Motas

6 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Motas Spain 6 215 150 146 94 77 6 359
Luca Maggioni Spain 5 168 0.8× 141 0.9× 156 1.1× 77 0.8× 53 0.7× 7 321
Aaron S. Meadows United States 11 176 0.8× 189 1.3× 178 1.2× 86 0.9× 51 0.7× 13 383
Sara Marcó Spain 11 368 1.7× 239 1.6× 240 1.6× 148 1.6× 124 1.6× 14 580
Aiyin Liao United Kingdom 8 270 1.3× 149 1.0× 63 0.4× 80 0.9× 119 1.5× 14 376
Darren Murrey United States 11 133 0.6× 226 1.5× 105 0.7× 43 0.5× 49 0.6× 13 351
Brandon L. Brunson United States 12 220 1.0× 171 1.1× 121 0.8× 120 1.3× 74 1.0× 15 385
Kerry O. Cresawn United States 8 208 1.0× 241 1.6× 136 0.9× 67 0.7× 134 1.7× 9 438
Ana Kolicheski United States 11 100 0.5× 105 0.7× 60 0.4× 36 0.4× 48 0.6× 18 343
Alisa A. Shaimardanova Russia 8 121 0.6× 257 1.7× 176 1.2× 50 0.5× 55 0.7× 13 426
Johan Deniaud France 6 103 0.5× 164 1.1× 137 0.9× 51 0.5× 23 0.3× 9 280

Countries citing papers authored by Sandra Motas

Since Specialization
Citations

This map shows the geographic impact of Sandra Motas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Motas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Motas more than expected).

Fields of papers citing papers by Sandra Motas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Motas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Motas. The network helps show where Sandra Motas may publish in the future.

Co-authorship network of co-authors of Sandra Motas

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Motas. A scholar is included among the top collaborators of Sandra Motas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Motas. Sandra Motas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Roca, Carles, Sandra Motas, Sara Marcó, et al.. (2017). Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID. Human Molecular Genetics. 26(8). 1535–1551. 43 indexed citations
2.
Motas, Sandra, Virginia Haurigot, Miquel García, et al.. (2016). CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome). JCI Insight. 1(9). e86696–e86696. 56 indexed citations
3.
Marcó, Sara, Anna Pujol, Carles Roca, et al.. (2016). Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC. Disease Models & Mechanisms. 9(9). 999–1013. 18 indexed citations
4.
Ribera, Albert, Virginia Haurigot, Miquel García, et al.. (2014). Biochemical, histological and functional correction of mucopolysaccharidosis Type IIIB by intra-cerebrospinal fluid gene therapy. Human Molecular Genetics. 24(7). 2078–2095. 46 indexed citations
5.
Haurigot, Virginia, Sara Marcó, Albert Ribera, et al.. (2013). Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy. Journal of Clinical Investigation. 123(8). 3254–3271. 176 indexed citations
6.
Villacampa, Pilar, Albert Ribera, Sandra Motas, et al.. (2013). Insulin-like Growth Factor I (IGF-I)-induced Chronic Gliosis and Retinal Stress Lead to Neurodegeneration in a Mouse Model of Retinopathy. Journal of Biological Chemistry. 288(24). 17631–17642. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026